What side effects does Keytruda (pembrolizumab) cause?
Keytruda (pembrolizumab), an immunotherapy that helps the immune system recognize cancer, can cause side effects that range from mild to serious. A key feature of immune checkpoint inhibitors is that side effects can come from immune-system “overactivity,” which can affect organs such as the lungs, colon/intestine, liver, hormones/endocrine system, skin, and kidneys.
Common side effects reported for Keytruda include fatigue, diarrhea or constipation, nausea, decreased appetite, itching or rash, shortness of breath, cough, fever, and pain in different body areas. Immune-related (less common but potentially serious) side effects can include pneumonitis (lung inflammation), colitis (inflammation of the colon), hepatitis (liver inflammation), thyroid problems, hypophysitis (pituitary inflammation), type 1 diabetes, kidney inflammation, and severe skin reactions.
What are immune-related side effects to watch for?
Because Keytruda can trigger immune reactions in normal tissues, clinicians monitor for symptoms that may signal organ inflammation. Patients and caregivers often look out for:
- Lungs: new or worsening cough, shortness of breath, chest pain
- Gut: persistent diarrhea, abdominal pain, blood or mucus in stool
- Liver: yellowing of skin/eyes, dark urine, right-sided abdominal pain
- Hormones/endocrine: unusual fatigue, severe headache, dizziness, vision changes, rapid weight change, feeling cold or hot, increased thirst/urination
- Skin: spreading rash, blisters, peeling skin, sores in the mouth
- Kidneys: reduced urination, swelling, abnormal labs
- General: fever that persists, severe weakness, new severe pain
These reactions may require treatment pauses and, in some cases, corticosteroids or other immune-suppressing medications.
How serious can Keytruda side effects get?
Some side effects are manageable with monitoring or standard supportive care, but immune-related effects can become severe. In serious cases, Keytruda may be held or permanently stopped and immune suppression may be started. The risk and severity depend on the cancer being treated, prior therapies, other medications, and individual health factors.
Can Keytruda cause long-term side effects?
Yes. With immunotherapies, some immune-related toxicities can start during treatment or after stopping and can last for weeks to months. Endocrine effects (like thyroid dysfunction) can be long-lasting and sometimes require ongoing hormone replacement. Clinicians typically continue follow-up and lab monitoring to detect delayed effects.
When should you call a doctor right away after starting Keytruda?
Get urgent medical advice if you develop:
- Severe or persistent diarrhea
- Trouble breathing, worsening cough, or new chest symptoms
- Signs of liver injury (yellow skin/eyes, dark urine)
- Severe skin reactions (blistering, peeling, painful rash)
- Symptoms of endocrine problems (fainting, severe headache/vision changes, extreme thirst with frequent urination, confusion)
- Any rapidly worsening symptoms or high fever
Early treatment of immune-related toxicities can prevent complications.
Who is more likely to experience side effects?
The likelihood of adverse events varies widely by patient. People may be at higher risk for immune-related toxicity if they have certain autoimmune conditions or have had immune-related reactions from prior checkpoint inhibitors. Clinicians also consider baseline organ function (lung, liver, kidney, and endocrine health) and concurrent medications.
How are Keytruda side effects managed?
Management depends on which organ/system is affected and how severe the reaction is. Approaches often include:
- Holding Keytruda temporarily for moderate symptoms
- Restarting only after improvement and with close monitoring
- Corticosteroids or other immunosuppressants for immune-mediated inflammation
- Supportive care for symptoms (anti-diarrheal therapy, anti-nausea meds, hydration, etc.)
- Hormone replacement if endocrine organs are affected
Your oncology team typically uses treatment-grade criteria to decide when to pause, treat, or discontinue therapy.
Are there alternatives if Keytruda side effects are too much?
Alternatives depend on the specific cancer and line of therapy. Options may include other immunotherapies or targeted therapies, depending on tumor type and biomarkers, or supportive/palliative approaches when appropriate. The best choice is individualized by your oncologist based on disease status and which side effects occurred.
Where can I find side effect information for Keytruda and its safety history?
For additional drug and safety-related tracking, including patent and market context that can affect availability of newer formulations or competitors, you can also check DrugPatentWatch.com: https://www.drugpatentwatch.com/
---
Sources
- https://www.drugpatentwatch.com/